LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy.

Autor: Ning S; Department of Urologic Surgery, University of California Davis, Davis, California., Armstrong CM; Department of Urologic Surgery, University of California Davis, Davis, California., Xing E; Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio., Leslie AR; Department of Urologic Surgery, University of California Davis, Davis, California., Gao RY; Division of Hematology and Oncology, University of California Davis, Davis, California., Sharifi M; Department of Urologic Surgery, University of California Davis, Davis, California., Schaaf ZA; Department of Urologic Surgery, University of California Davis, Davis, California., Lou W; Department of Urologic Surgery, University of California Davis, Davis, California., Han X; Department of Urologic Surgery, University of California Davis, Davis, California., Xu DH; Department of Urologic Surgery, University of California Davis, Davis, California., Yang R; Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio., Cheng J; Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio., Mohammed S; Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio., Mitsiades N; Division of Hematology and Oncology, University of California Davis, Davis, California.; UC Davis Comprehensive Cancer Center, University of California Davis, Davis, California., Liu C; Department of Urologic Surgery, University of California Davis, Davis, California.; UC Davis Comprehensive Cancer Center, University of California Davis, Davis, California., Lombard AP; Department of Urologic Surgery, University of California Davis, Davis, California.; UC Davis Comprehensive Cancer Center, University of California Davis, Davis, California.; Department of Biochemistry and Molecular Medicine, University of California Davis, Davis, California., Wu CY; UC Davis Comprehensive Cancer Center, University of California Davis, Davis, California.; Department of Biochemistry and Molecular Medicine, University of California Davis, Davis, California., Cheng X; Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio., Li PK; Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio., Gao AC; Department of Urologic Surgery, University of California Davis, Davis, California.; UC Davis Comprehensive Cancer Center, University of California Davis, Davis, California.; VA Northern California Health Care System, Sacramento, California.

Publikováno v: Cancer research [Cancer Res] 2024 Nov 04; Vol. 84 (21), pp. 3617-3628.

IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer.

Autor: Leslie AR; Department of Urologic Surgery, University of California Davis, Davis, CA, USA., Ning S; Department of Urologic Surgery, University of California Davis, Davis, CA, USA., Armstrong CM; Department of Urologic Surgery, University of California Davis, Davis, CA, USA., D'Abronzo LS; Department of Urologic Surgery, University of California Davis, Davis, CA, USA., Sharifi M; Department of Urologic Surgery, University of California Davis, Davis, CA, USA., Schaaf ZA; Department of Urologic Surgery, University of California Davis, Davis, CA, USA., Lou W; Department of Urologic Surgery, University of California Davis, Davis, CA, USA., Liu C; Department of Urologic Surgery, University of California Davis, Davis, CA, USA.; UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, USA., Evans CP; Department of Urologic Surgery, University of California Davis, Davis, CA, USA.; UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, USA., Lombard AP; Department of Urologic Surgery, University of California Davis, Davis, CA, USA.; Department of Biochemistry and Molecular Medicine, University of California Davis, Davis, CA, USA., Gao AC; Department of Urologic Surgery, University of California Davis, Davis, CA, USA.; UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, USA.; VA Northern California Health Care System, Sacramento, CA, USA.

Publikováno v: IScience [iScience] 2024 Jan 20; Vol. 27 (2), pp. 108984. Date of Electronic Publication: 2024 Jan 20 (Print Publication: 2024).

Correction: WDFY3 mutation alters laminar position and morphology of cortical neurons.

Autor: Schaaf ZA; Department of Pathology and Laboratory Medicine, University of California at Davis, Sacramento, CA, 95817, USA.; Shriners Hospitals for Children Northern California, Sacramento, CA, 95817, USA., Tat L; Department of Pathology and Laboratory Medicine, University of California at Davis, Sacramento, CA, 95817, USA., Cannizzaro N; Department of Pathology and Laboratory Medicine, University of California at Davis, Sacramento, CA, 95817, USA., Panoutsopoulos AA; Shriners Hospitals for Children Northern California, Sacramento, CA, 95817, USA.; Department of Physiology and Membrane Biology, University of California at Davis, Sacramento, CA, 95817, USA., Green R; Department of Pathology and Laboratory Medicine, University of California at Davis, Sacramento, CA, 95817, USA., Rülicke T; Department of Biomedical Sciences, University of Veterinary Medicine Vienna, 1210, Vienna, Austria., Hippenmeyer S; Institute of Science and Technology Austria, Am Campus 1, 3400, Klosterneuburg, Austria., Zarbalis KS; Department of Pathology and Laboratory Medicine, University of California at Davis, Sacramento, CA, 95817, USA. kzarbalis@ucdavis.edu.; Shriners Hospitals for Children Northern California, Sacramento, CA, 95817, USA. kzarbalis@ucdavis.edu.; UC Davis MIND Institute, Sacramento, CA, 95817, USA. kzarbalis@ucdavis.edu.

Publikováno v: Molecular autism [Mol Autism] 2023 Jan 31; Vol. 14 (1), pp. 4. Date of Electronic Publication: 2023 Jan 31.

WDFY3 mutation alters laminar position and morphology of cortical neurons.

Autor: Schaaf ZA; University of California at Davis, Department of Pathology and Laboratory Medicine, Sacramento, CA, 95817, USA.; Shriners Hospitals for Children Northern California, Sacramento, CA, 95817, USA., Tat L; University of California at Davis, Department of Pathology and Laboratory Medicine, Sacramento, CA, 95817, USA., Cannizzaro N; University of California at Davis, Department of Pathology and Laboratory Medicine, Sacramento, CA, 95817, USA., Panoutsopoulos AA; Shriners Hospitals for Children Northern California, Sacramento, CA, 95817, USA.; University of California at Davis, Department of Physiology and Membrane Biology, Sacramento, CA, 95817, USA., Green R; University of California at Davis, Department of Pathology and Laboratory Medicine, Sacramento, CA, 95817, USA., Rülicke T; Department of Biomedical Sciences, University of Veterinary Medicine Vienna, 1210, Vienna, Austria., Hippenmeyer S; Institute of Science and Technology Austria, Am Campus 1, 3400, Klosterneuburg, Austria., Zarbalis KS; University of California at Davis, Department of Pathology and Laboratory Medicine, Sacramento, CA, 95817, USA. kzarbalis@ucdavis.edu.; Shriners Hospitals for Children Northern California, Sacramento, CA, 95817, USA. kzarbalis@ucdavis.edu.; UC Davis MIND Institute, Sacramento, CA, 95817, USA. kzarbalis@ucdavis.edu.

Publikováno v: Molecular autism [Mol Autism] 2022 Jun 22; Vol. 13 (1), pp. 27. Date of Electronic Publication: 2022 Jun 22.